康芝药业 (300086)

HONZ PHARMACEUTICAL CO., LTD.

ASZ

Tags

Generic DrugsInnovative DrugsPharmaceutical ManufacturingFace Mask ProtectionInfant and Child ConceptHelicobacter PyloriPrivate HospitalsActive StocksHainan Free Trade ZoneHepatitis ConceptEquity TransferAssisted Reproduction

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 45512.44
  • Circulating A-Shares(W): 44068.25
  • Earnings Per Share(RMB): -0.2123
  • Net Assets Per Share(RMB): 2.3064
  • Operating Revenue(W RMB): 32638.21
  • Total Profit(W RMB): -11183.67
  • Net Profit Attributable to Parent(W RMB): -9661.15
  • Net Profit Growth Rate(%): 21.28
  • Weighted Return on Equity(%): -8.8500
  • Operating Cash Flow Per Share(RMB): 0.1260
  • Undistributed Profit Per Share(RMB): -0.7942
  • Capital Reserve Per Share(RMB): 1.8522

2. Main Business

The main business covers:

  • Children's medicine
  • R&D, production, and sales of maternal and infant health products
  • Medical protective supplies and other medical devices

3. Company Basic Information

  • Company Name: Honz Pharmaceutical Co., Ltd.
  • Listing Date: 2010-05-26
  • Industry: Pharmaceutical Manufacturing
  • Address: No.6 Yaogu 3rd Road, Yaogu Industrial Park, Haikou National High-tech Industrial Development Zone, Hainan Province, and 26th Floor, Guangzhou Dongshan Plaza
  • Website: www.honz.com.cn
  • Company Profile: In December 2007, Hainan Zhongrui Kangzhi Pharmaceutical Co., Ltd. was restructured into Hainan Kangzhi Pharmaceutical Co., Ltd. based on its audited net assets of RMB 115,573,883.95 as of November 30, 2007, converted into 75 million shares at a ratio of 1:0.64935. The company completed the industrial and commercial registration change at the Hainan Provincial Administration for Industry and Commerce on December 28, 2007, obtained the business license with registration number 460000000017507, with a registered capital of RMB 75 million and legal representative Hong Jiangyou.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hainan Hongshi Investment Co., Ltd. General Legal Person 12403.87 28.15
2 J. P. Morgan Securities PLC - Proprietary Funds QFII 190.81 0.43
3 BARCLAYS BANK PLC QFII 159.10 0.36

5. Concept Sectors

  • Hainan Free Trade Port
  • Infant & Child Concept
  • Private Hospitals
  • Generic Drugs
  • Mask Protection
  • Helicobacter Pylori
  • Assisted Reproduction
  • Hepatitis Concept
  • Innovative Drugs
  • Active Stocks
  • Consecutive Losses
  • Equity Transfer

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information